Antitumor Paclitaxel Apis

Ibisobanuro bigufi:

Ibikoresho fatizo bya Paclitaxel ni imiti ikoreshwa mu gukora imiti igabanya ubukana kandi kuri ubu ni umwe mu miti ikoreshwa cyane mu bikorwa by’ubuvuzi. Ubusanzwe yari uruganda rusanzwe rwakuwe mu kibabi cy’amagi ya Taxus chinensis, nyuma ruza kuboneka binyuze mu buryo butandukanye nka synthesis ya chimique hamwe na synthesis ya kabiri.Hande Biology itanga Antitumor Paclitaxel Apis.Niba ubikeneye, nyamuneka twandikire kumurongo umwanya uwariwo wose.

Ohereza imeri kuri twe

Ibicuruzwa birambuye

Ibicuruzwa

Amakuru y'ibicuruzwa

Izina:Antitumor Paclitaxel Apis

Numero ya CAS:33069-62-4

Ibisobanuro:99% -102%

Ubwoko:APIs

Uruhare rwibikoresho fatizo bya paclitaxel

Ibikoresho fatizo bya paclitaxel bigira ingaruka zitandukanye za anticancer kandi birashobora kubuza gukura no gukwirakwiza kwingirangingo yibibyimba hakoreshejwe uburyo butandukanye.Uruhare runini cyane ni ukubangamira mitito ya selile yibibyimba muguhagarika microtubule hamwe no kubora, bityo bigatuma apoptose yibibyimba cyangwa se urupfu. Byongeye kandi, paclitaxel irashobora kandi kubuza ikibyimba angiogenez, kugabanya imirire yibibyimba, no kongera ibyiyumvo byingirabuzimafatizo yibibyimba bivura imirasire.

Kugeza ubu, paclitaxel yakoreshejwe cyane mu kuvura ibibyimba bitandukanye, nka kanseri y'intanga, kanseri y'ibere, kanseri y'ibihaha, kanseri y'igifu, n'ibindi. Irashobora gukoreshwa wenyine cyangwa ifatanije n'indi miti igabanya ubukana kugira ngo ivure neza. Muri icyo gihe, paclitaxel API irashobora kandi gukoreshwa mugutezimbere imiti mishya irwanya kanseri, nk'abatwara nanoparticle, paclitaxel yahinduwe, nibindi.